Clinical Trial Detail

NCT ID NCT03319745
Title A Window of Opportunity Study of Pembrolizumab in Patients With Bladder Cancer Undergoing Radical Cystectomy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

urinary bladder cancer

bladder urothelial carcinoma

bladder carcinoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.